Clinical Trials · NCT01507311
Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 11
- Start date
- Sep 1999
- Locations
- 1 site, Denmark
- Primary endpoint
- Insulin secretory burst mass